Forbes -
13 Oct 2017 19:40
Johnson & Johnson will report its Q3 2017 earnings on October 17, and we expect the company to post solid numbers, owing to three primary factors - a ramp up in key oncology drug sales, the Actelion acquisition, and forex gains.
Share this Article